We work to the specific requirements of your study needs, with a centralized, fully adaptable spirometry system. Clinicians can capture pulmonary function testing data and measure the impact of the fibrosis in clinical trial subjects, and resting spirometry and gas transfer measurements can be entered on our system, and included as part of the central database.
We offer a range of centralized pulmonary function testing (PFT) endpoints and customizable reports for data monitoring and analysis, and quick and easy access to subject matter experts throughout the life of your study.
We provide you with:
We support Interstitial Lung Disease clinical trials including Idiopathic Pulmonary Fibrosis, Sarcoidosis and Scleroderma. Vitalograph is the Interstitial Lung Disease study partner of choice for many leading pharmaceutical companies and CROs, who regularly come back to us for repeat business.
Being a market leader in respiratory medical devices for over 50 years, we have a wealth of expertise in respiratory testing and monitoring. We also know the importance of accuracy in study endpoints and safety, and provide data you can rely on.
Our internationally renowned Over-readers ensure high-quality data and feedback for your trial, improving site data, compliance and performance.
Our experienced teams of highly qualified and responsive project and data managers mean decisions can be made quickly. We are flexible in our approach and, being fully aware of the importance of timelines, prompt feedback is provided for any query. We ensure key milestones are met and trials are delivered speedily.
We provide accurate, reliable and precise Interstitial Lung Disease clinical trial objectives and endpoints.
Speak to our team about our experience and how our services can benefit your study.